Description
Carfilzomib, marketed under the brand name Kyprolis, It is an prescription medication that has been approved carfilzomib in 2012, under its accelerated approval program, for use alone in patients with multiple myeloma whose cancer has progressed after receiving at least two previous therapies, including bortezomib and an immunomodulatory agent (such as lenalidomide or thalidomide).
What is Kyprolis (Carfilzomib) ?
INDICATIONS. KYPROLIS® (carfilzomib) is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy.
Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.
How to order approved “Kyprolis (Carfilzomib) for Injection” Medicine?
Kyprolis (Carfilzomib) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing Kyprolis and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
We can ship to :
Verve Biosciences offers assistance in importing the anti-cancer medication Kyprolis (Carfilzomib) for Injection. To inquire about the total cost of Kyprolis (Carfilzomib) for Injection in various countries, including UAE, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, as well as Europe (such as UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Maldova, Germany, Sweden, Italy, Bulgaria, Romania, Montenegro, Russia), and other countries like Zimbabwe, Australia, and New Zealand, Canada, Philippines, USA, South Africa, Thailand, China, Pakistan, Kazakhstan, Uzbekistan, Zambia, Kuwait, Sri Lanka, Singapore, Hong Kong, Afghanistan, Turkey, Malaysia, Qatar, Japan, Nepal, and many other countries. please reach out to us. We will provide you with the necessary information regarding the pricing and availability of Kyprolis (Carfilzomib) for Injection in the desired locations.
How to Get Access
If the Brand Name medication “Kyprolis (Carfilzomib) for Injection” is not approved or unavailable in your country, patients, physicians, and distributors/suppliers have the option to purchase and import it from Verve Biosciences. To begin the process, you can make an enquiry, and we will assist you in calculating the total cost to buy “Kyprolis (Carfilzomib) for Injection” online and arrange delivery to your location. To proceed, we will require a prescription from your treating doctor, and in certain countries, an import license may also be necessary. Throughout the process, our Patient Support team will provide guidance and support.
Verve Biosciences Pvt. Ltd.
Contact Person : Mr Rakesh Khanna
Email: info@cancermedicinesnetwork.com
Mobile: 91 9910645395
WhatsApp: +919910645395
FAQ's
How much does Kyprolis cost?
The Kyprolis price in India usually can vary depending on the wholesaler/pharmacy you visit. Kyprolis is available as a brand name drug only, a generic version is not yet available.
What is the best price for Carfilzomib?
Please contact at urgent@cancermedicinesnetwork.com : (+91) 9910645395 for Carfilzomib price India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Can I get Kyprolis (Carfilzomib) for Injection even if I am not based in India?
The Verve Biosciences helps patients in accessing or importing Kyprolis (Carfilzomib), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.
